MMP13 and nasopharyngeal carcinoma: MMP-13 that reportedly has been shown to be overexpressed in various tumors and is associated with increased risk of metastasis in patients with head and neck cancer [109,110], was recently detected in nasopharyngeal cancer (NPC) patient plasma-derived EVs [94].